Cite

HARVARD Citation

    Grover, N. et al. (2021). Extending the Promise of Chimeric Antigen Receptor T-Cell Therapy Beyond Targeting CD19+ Tumors. Journal of clinical oncology. 39 (5), pp. 499-513. [Online]. 
  
Back to record